These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 8413453)

  • 1. Outpatient management without antibiotics of fever in selected infants.
    Baker MD; Bell LM; Avner JR
    N Engl J Med; 1993 Nov; 329(20):1437-41. PubMed ID: 8413453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and cost-effectiveness of outpatient strategies for management of febrile infants.
    Lieu TA; Baskin MN; Schwartz JS; Fleisher GR
    Pediatrics; 1992 Jun; 89(6 Pt 2):1135-44. PubMed ID: 1594366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized study of outpatient treatment with ceftriaxone for selected febrile children with sickle cell disease.
    Wilimas JA; Flynn PM; Harris S; Day SW; Smith R; Chesney PJ; Rodman JH; Eguiguren JM; Fairclough DL; Wang WC
    N Engl J Med; 1993 Aug; 329(7):472-6. PubMed ID: 8332152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Febrile infants at low risk for serious bacterial infection--an appraisal of the Rochester criteria and implications for management. Febrile Infant Collaborative Study Group.
    Jaskiewicz JA; McCarthy CA; Richardson AC; White KC; Fisher DJ; Dagan R; Powell KR
    Pediatrics; 1994 Sep; 94(3):390-6. PubMed ID: 8065869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of low-risk criteria in the evaluation of young infants with fever: review of the literature.
    Huppler AR; Eickhoff JC; Wald ER
    Pediatrics; 2010 Feb; 125(2):228-33. PubMed ID: 20083517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
    Mullen CA; Petropoulos D; Roberts WM; Rytting M; Zipf T; Chan KW; Culbert SJ; Danielson M; Jeha SS; Kuttesch JF; Rolston KV
    Cancer; 1999 Jul; 86(1):126-34. PubMed ID: 10391572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Charges and complications associated with the medical evaluation of febrile young infants.
    Condra CS; Parbhu B; Lorenz D; Herr SM
    Pediatr Emerg Care; 2010 Mar; 26(3):186-91. PubMed ID: 20179660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reappraisal of criteria used to predict serious bacterial illness in febrile infants less than 8 weeks of age.
    Garra G; Cunningham SJ; Crain EF
    Acad Emerg Med; 2005 Oct; 12(10):921-5. PubMed ID: 16204135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of febrile infants under 3 months of age: is routine lumbar puncture warranted?
    Brik R; Hamissah R; Shehada N; Berant M
    Isr J Med Sci; 1997 Feb; 33(2):93-7. PubMed ID: 9254869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer.
    Quezada G; Sunderland T; Chan KW; Rolston K; Mullen CA
    Pediatr Blood Cancer; 2007 Mar; 48(3):273-7. PubMed ID: 16435377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The febrile infant.
    McCutcheon ML
    J Fam Pract; 1985 Jun; 20(6):584-8. PubMed ID: 3998673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outbreak of life-threatening thiamine deficiency in infants in Israel caused by a defective soy-based formula.
    Fattal-Valevski A; Kesler A; Sela BA; Nitzan-Kaluski D; Rotstein M; Mesterman R; Toledano-Alhadef H; Stolovitch C; Hoffmann C; Globus O; Eshel G
    Pediatrics; 2005 Feb; 115(2):e233-8. PubMed ID: 15687431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced urinalysis improves identification of febrile infants ages 60 days and younger at low risk for serious bacterial illness.
    Herr SM; Wald ER; Pitetti RD; Choi SS
    Pediatrics; 2001 Oct; 108(4):866-71. PubMed ID: 11581437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein as a marker of serious bacterial infections in hospitalized febrile infants.
    Bilavsky E; Yarden-Bilavsky H; Ashkenazi S; Amir J
    Acta Paediatr; 2009 Nov; 98(11):1776-80. PubMed ID: 19664100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of febrile neonates unlikely to have bacterial infections.
    Chiu CH; Lin TY; Bullard MJ
    Pediatr Infect Dis J; 1997 Jan; 16(1):59-63. PubMed ID: 9002103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of cerebrospinal fluid pleocytosis in febrile infants aged 0 to 90 days.
    Meehan WP; Bachur RG
    Pediatr Emerg Care; 2008 May; 24(5):287-93. PubMed ID: 18496111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serious bacterial infections in febrile infants in the post-pneumococcal conjugate vaccine era.
    Rudinsky SL; Carstairs KL; Reardon JM; Simon LV; Riffenburgh RH; Tanen DA
    Acad Emerg Med; 2009 Jul; 16(7):585-90. PubMed ID: 19538500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial.
    Hidalgo M; Hornedo J; Lumbreras C; Trigo JM; Colomer R; Perea S; Gómez C; Ruiz A; García-Carbonero R; Cortés-Funes H
    Cancer; 1999 Jan; 85(1):213-9. PubMed ID: 9921995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serious bacterial infections in febrile outpatient pediatric heart transplant recipients.
    Yin S; Trainor JL; Powell EC
    Acad Emerg Med; 2009 Oct; 16(10):942-8. PubMed ID: 19799569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.